NX PHARMAGEN INC.

Profile

Company Names

NX PHARMAGEN INC.

Addresses

4350 BROWNSBORO ROAD, SUITE 110, LOUISVILLE, KY 40207

Phone Numbers

502-741-5047

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$1,849,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-10-10 
$590,000.00 
$1,000,000.00 
$410,000.00 
Debt 
2
2020-08-17 
$486,000.00 
$1,000,000.00 
$514,000.00 
Equity 
1
2013-06-24 
$773,000.00 
$1,000,000.00 
$227,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
BROHMAN 
EXECUTIVE OFFICER, DIRECTOR
NX DEVELOPMENT CORP.   |  NX PRENATAL INC.   |  NX PHARMAGEN INC.   |  NEXOSOME ONCOLOGY HOLDINGS, INC.
BRIAN 
D. 
BROHMAN 
EXECUTIVE OFFICER, DIRECTOR
NX PHARMAGEN INC.
PASCAL 
 
DESCHATELETS 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  NX PHARMAGEN INC.   |  REVON SYSTEMS, LLC
ALAN 
 
EZRIN 
DIRECTOR
NX DEVELOPMENT CORP.   |  BRADMER PHARMACEUTICALS INC   |  NX PHARMAGEN INC.   |  NEXOSOME ONCOLOGY HOLDINGS, INC.
ALAN 
M. 
EZRIN 
EXECUTIVE OFFICER, DIRECTOR
NX PHARMAGEN INC.
CEDRIC 
 
FRANCOIS 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  NX PHARMAGEN INC.   |  REVON SYSTEMS, LLC   |  REVON SYSTEMS, INC.   |  LIBERATE MEDICAL, INC.   |  ACUAMARK DIAGNOSTICS, INC.
FRED 
 
MERMELSTEIN 
DIRECTOR
NX PHARMAGEN INC.   |  ADVANTAGENE, INC.   |  NX DEVELOPMENT CORP.   |  SANARX BIOTHERAPEUTICS, INC   |  NEXTRNA THERAPEUTICS, INC.
ROBERT 
 
SAUNDERS 
DIRECTOR
TECHSKILLS LLC   |  SS1 ACQUISITION, LLC   |  VIVORTE INC.   |  IF TECHNOLOGIES, INC   |  DF DISTRESSED EQUITY PROPERTY FUND I, L.P.   |  DF DISTRESSED MEZZANINE PROPERTY FUND I, L.P.   |  COBRA STYLET L.L.C.   |  NX PHARMAGEN INC.   |  ADVANCED RESOURCE TECHNOLOGIES (ART) LLC   |  ADVANCED RESOURCE TECHNOLOGY DEVELOPMENT LLC   |  OCA VENTURES III, L.P.   |  NX DEVELOPMENT CORP.   |  REGROUP THERAPY INC.   |  NX PRENATAL INC.   |  SEIKOWAVE DENTAL, INC.   |  PROGENTEC DIAGNOSTICS, INC.   |  OCA VENTURES IV, L.P.   |  NOVEL COWORKING FUND III - A, LP   |  NOVEL COWORKING FUND III - B, LP   |  NOVEL COWORKING FUND III - I, LP   |  SEIKOWAVE HEALTH SOLUTIONS, INC.   |  EBLU SOLUTIONS, INC.   |  AMOPPORTUNITIES, INC.   |  CA STUDENT LIVING INCOME + GROWTH, LP   |  CA STUDENT LIVING INCOME + GROWTH FEEDER, LP   |  CA STUDENT LIVING INCOME + GROWTH (PARALLEL), LP   |  NEXOSOME ONCOLOGY HOLDINGS, INC.   |  CA STUDENT LIVING INVESTMENT FUND REIT, LLC   |  OCA VENTURES GROWTH FUND, L.P.   |  INNOVATIVE THERAPEUTIX, INC.   |  EBLU SOLUTIONS INC.   |  AMPLIFIED SCIENCES, INC.   |  DESICORP, INC.   |  EQL GAMES INC.   |  IPILL INC.   |  OCA ROADRUNNER II, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-10 
2020-08-31
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-17 
2013-06-25
D
Link
OTHER HEALTH CARE 
 
NO REVENUES 
Debt 
2013-06-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#